GlassScriptPhysician profile
Robert G Valentine
NPI 1730164161
$8,915.87
in general payments reported to CMS, 2019-2025
58 companies · $1,453 in 2025
The $1,453 reported for 2025 was more than what 76% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,208 · 2020: $1,073 · 2021: $1,518 · 2022: $1,037 · 2023: $1,064 · 2024: $1,562 · 2025: $1,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,034 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,033.77 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,831.48 | 2019-2025 | Xtampza, Belbuca |
| Nevro Corp. | $1,106.63 | 2019-2024 | Senza |
| Medtronic, INC. | $760.93 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Abbvie INC. | $624.71 | 2021-2025 | Botox |
| Abbott Laboratories | $550.02 | 2019-2025 | Proclaim |
| Pfizer INC. | $548.00 | 2023-2025 | |
| Saluda Medical Americas, INC. | $390.98 | 2024-2025 | Evoke |
| Biohaven Pharmaceutical Holding Company LTD. | $292.09 | 2022 | |
| Tersera Therapeutics LLC | $268.91 | 2024-2025 | Prialt |
| Boston Scientific Corporation | $236.49 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Allergan, INC. | $200.79 | 2019-2021 | |
| Averitas Pharma INC. | $191.83 | 2024-2025 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $187.03 | 2019-2025 | Relistor |
| Amgen INC. | $178.45 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $135.40 | 2021-2024 | Ztlido |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Valentine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.